Standard Diagnostics

Standard Diagnostics, Inc. (SD) is a global leader in the development and manufacture of rapid in vitro diagnostic (IVD) solutions, headquartered in South Korea. The company is best known for its SD BIOLINE brand, which encompasses a wide array of rapid tests for infectious diseases including malaria, HIV, hepatitis, and respiratory infections. Acquired by Alere in 2010 and subsequently becoming part of Abbott in 2017, SD's technology platforms—ranging from lateral flow assays to fluorescent immunoassays—are utilized extensively in point-of-care settings worldwide. Their products play a vital role in public health, particularly in resource-limited settings where laboratory infrastructure is minimal. The company continues to innovate in the fields of molecular diagnostics and chronic disease management.